Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray).

Grimaldi AE, De Giglio L, Haggiag S, Bianco A, Cortese A, Crisafulli SG, Monteleone F, Marfia G, Prosperini L, Galgani S, Mirabella M, Centonze D, Pozzilli C, Castelli L.

PLoS One. 2019 Jul 30;14(7):e0219670. doi: 10.1371/journal.pone.0219670. eCollection 2019.

2.

Effect of dalfampridine on information processing speed impairment in multiple sclerosis.

De Giglio L, De Luca F, Gurreri F, Ferrante I, Prosperini L, Borriello G, Quartuccio E, Gasperini C, Pozzilli C.

Neurology. 2019 Aug 20;93(8):e733-e746. doi: 10.1212/WNL.0000000000007970. Epub 2019 Jul 22.

PMID:
31331968
3.

Erratum to "The Role of fMRI in the Assessment of Neuroplasticity in MS: A Systematic Review".

De Giglio L, Tommasin S, Petsas N, Pantano P.

Neural Plast. 2019 Jun 3;2019:5181649. doi: 10.1155/2019/5181649. eCollection 2019.

4.

Advances in preventing adverse events during monoclonal antibody management of multiple sclerosis.

De Giglio L, Grimaldi AE, Fubelli F, Marinelli F, Pozzilli C.

Expert Rev Neurother. 2019 May;19(5):417-429. doi: 10.1080/14737175.2019.1610393. Epub 2019 May 16.

PMID:
31094239
5.

Functional Connectivity Changes After Initial Treatment With Fingolimod in Multiple Sclerosis.

Petsas N, De Giglio L, González-Quintanilla V, Giuliani M, De Angelis F, Tona F, Carmellini M, Mainero C, Pozzilli C, Pantano P.

Front Neurol. 2019 Mar 22;10:153. doi: 10.3389/fneur.2019.00153. eCollection 2019.

6.

Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online.

Lavorgna L, Borriello G, Esposito S, Abbadessa G, Capuano R, De Giglio L, Logoteta A, Pozzilli C, Tedeschi G, Bonavita S.

Mult Scler Relat Disord. 2019 Jan;27:239-246. doi: 10.1016/j.msard.2018.10.113. Epub 2018 Nov 5.

PMID:
30419509
7.

Relation between functional connectivity and disability in multiple sclerosis: a non-linear model.

Tommasin S, De Giglio L, Ruggieri S, Petsas N, Giannì C, Pozzilli C, Pantano P.

J Neurol. 2018 Dec;265(12):2881-2892. doi: 10.1007/s00415-018-9075-5. Epub 2018 Oct 1.

PMID:
30276520
8.

Listeria Monocytogenes-Induced Rhombencephalitis-A Paradoxical Disease of Immunocompetent Patients-Reply.

Ruggieri S, De Giglio L.

JAMA Neurol. 2018 Nov 1;75(11):1442-1443. doi: 10.1001/jamaneurol.2018.2744. No abstract available.

PMID:
30264091
9.

Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study.

Mirabella M, Prosperini L, Lucchini M, Boffa L, Borriello G, Buscarinu MC, Centonze D, Cortese A, De Fino C, De Giglio L, Elia G, Fantozzi R, Ferraro E, Francia A, Galgani S, Gasperini C, Haggiag S, Landi D, Marfia GA, Millefiorini E, Monteleone F, Nociti V, Salvetti M, Sgarlata E, Pozzilli C.

CNS Drugs. 2018 Oct;32(10):963-970. doi: 10.1007/s40263-018-0543-3.

PMID:
30022464
10.

Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study.

Prosperini L, Lucchini M, Haggiag S, Bellantonio P, Bianco A, Buscarinu MC, Buttari F, Centonze D, Cortese A, De Giglio L, Fantozzi R, Ferraro E, Fornasiero A, Francia A, Galgani S, Gasperini C, Marfia GA, Millefiorini E, Nociti V, Pontecorvo S, Pozzilli C, Ruggieri S, Salvetti M, Sgarlata E, Mirabella M.

Neurology. 2018 Jul 10;91(2):e153-e161. doi: 10.1212/WNL.0000000000005772. Epub 2018 Jun 6.

PMID:
29875218
11.

Listeria monocytogenes-Induced Rhombencephalitis in a Patient With Multiple Sclerosis Treated With Dimethyl Fumarate.

Ruggieri S, Logoteta A, Martini G, Bozzao A, De Giglio L.

JAMA Neurol. 2018 Jun 1;75(6):762-763. doi: 10.1001/jamaneurol.2018.0368. No abstract available.

PMID:
29610843
12.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

Portaccio E, Annovazzi P, Ghezzi A, Zaffaroni M, Moiola L, Martinelli V, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Patti F, Solaro C, Bellantonio P, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e823-e831. doi: 10.1212/WNL.0000000000005067. Epub 2018 Feb 7.

PMID:
29438046
13.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.

Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Solaro C, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.

PMID:
29438041
14.

Role of Cerebellar Dentate Functional Connectivity in Balance Deficits in Patients with Multiple Sclerosis.

Tona F, De Giglio L, Petsas N, Sbardella E, Prosperini L, Upadhyay N, Giannì C, Pozzilli C, Pantano P.

Radiology. 2018 Apr;287(1):267-275. doi: 10.1148/radiol.2017170311. Epub 2017 Dec 22.

PMID:
29272214
15.

Neuroimaging Techniques to Assess Inflammation in Multiple Sclerosis.

Tommasin S, Giannì C, De Giglio L, Pantano P.

Neuroscience. 2019 Apr 1;403:4-16. doi: 10.1016/j.neuroscience.2017.07.055. Epub 2017 Jul 29. Review.

PMID:
28764938
16.

Lesion symptom map of cognitive-postural interference in multiple sclerosis.

Ruggieri S, Fanelli F, Castelli L, Petsas N, De Giglio L, Prosperini L.

Mult Scler. 2018 Apr;24(5):653-662. doi: 10.1177/1352458517701313. Epub 2017 Mar 24.

17.

Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial.

De Giglio L, Marinelli F, Barletta VT, Pagano VA, De Angelis F, Fanelli F, Petsas N, Pantano P, Tomassini V, Pozzilli C.

CNS Drugs. 2017 Feb;31(2):161-168. doi: 10.1007/s40263-016-0401-0.

PMID:
27995531
18.

Corpus callosum microstructural changes associated with Kawashima Nintendo Brain Training in patients with multiple sclerosis.

De Giglio L, Upadhyay N, De Luca F, Prosperini L, Tona F, Petsas N, Pozzilli C, Pantano P.

J Neurol Sci. 2016 Nov 15;370:211-213. doi: 10.1016/j.jns.2016.09.041. Epub 2016 Sep 22. No abstract available.

PMID:
27772761
19.

Task-dependent deterioration of balance underpinning cognitive-postural interference in MS.

Prosperini L, Castelli L, De Luca F, Fabiano F, Ferrante I, De Giglio L.

Neurology. 2016 Sep 13;87(11):1085-92. doi: 10.1212/WNL.0000000000003090. Epub 2016 Aug 12.

PMID:
27521436
20.

A lesion topography-based approach to predict the outcomes of patients with multiple sclerosis treated with Interferon Beta.

Galassi S, Prosperini L, Logoteta A, Hirsch MN, Fanelli F, De Giglio L, Pozzilli C.

Mult Scler Relat Disord. 2016 Jul;8:99-106. doi: 10.1016/j.msard.2016.05.012. Epub 2016 May 17.

PMID:
27456883
21.

Dentate nucleus connectivity in adult patients with multiple sclerosis: functional changes at rest and correlation with clinical features.

Sbardella E, Upadhyay N, Tona F, Prosperini L, De Giglio L, Petsas N, Pozzilli C, Pantano P.

Mult Scler. 2017 Apr;23(4):546-555. doi: 10.1177/1352458516657438. Epub 2016 Jul 18.

PMID:
27411700
22.

Multiple Sclerosis: Changes in Thalamic Resting-State Functional Connectivity Induced by a Home-based Cognitive Rehabilitation Program.

De Giglio L, Tona F, De Luca F, Petsas N, Prosperini L, Bianchi V, Pozzilli C, Pantano P.

Radiology. 2016 Jul;280(1):202-11. doi: 10.1148/radiol.2016150710. Epub 2016 Mar 8.

PMID:
26953867
23.

Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis.

De Giglio L, Marinelli F, Prosperini L, Contessa GM, Gurreri F, Piattella MC, De Angelis F, Barletta VT, Tomassini V, Pantano P, Pozzilli C.

Mediators Inflamm. 2015;2015:732539. doi: 10.1155/2015/732539. Epub 2015 Jul 8.

24.

Oral contraceptives combined with interferon β in multiple sclerosis.

Pozzilli C, De Giglio L, Barletta VT, Marinelli F, Angelis FD, Gallo V, Pagano VA, Marini S, Piattella MC, Tomassini V, Pantano P.

Neurol Neuroimmunol Neuroinflamm. 2015 Jun 18;2(4):e120. doi: 10.1212/NXI.0000000000000120. eCollection 2015 Aug.

25.

Investigating the phenomenon of "cognitive-motor interference" in multiple sclerosis by means of dual-task posturography.

Prosperini L, Castelli L, Sellitto G, De Luca F, De Giglio L, Gurreri F, Pozzilli C.

Gait Posture. 2015 Mar;41(3):780-5. doi: 10.1016/j.gaitpost.2015.02.002. Epub 2015 Feb 21.

PMID:
25770078
26.

Natalizumab discontinuation and disease restart in pregnancy: a case series.

De Giglio L, Gasperini C, Tortorella C, Trojano M, Pozzilli C.

Acta Neurol Scand. 2015 May;131(5):336-40. doi: 10.1111/ane.12364. Epub 2015 Jan 18.

PMID:
25598313
27.

A low-cost cognitive rehabilitation with a commercial video game improves sustained attention and executive functions in multiple sclerosis: a pilot study.

De Giglio L, De Luca F, Prosperini L, Borriello G, Bianchi V, Pantano P, Pozzilli C.

Neurorehabil Neural Repair. 2015 Jun;29(5):453-61. doi: 10.1177/1545968314554623. Epub 2014 Nov 14.

PMID:
25398725
28.

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.

Pecori C, Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Sturchio A, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, Mancardi GL, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

BMC Neurol. 2014 May 26;14:114. doi: 10.1186/1471-2377-14-114.

29.

Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.

Portaccio E, Ghezzi A, Hakiki B, Sturchio A, Martinelli V, Moiola L, Patti F, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, De Luca G, Paolicelli D, Marrosu MG, Comi G, Trojano M, Amato MP; MS Study Group of the Italian Neurological Society.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):845-50. doi: 10.1136/jnnp-2013-306054. Epub 2014 Jan 8.

PMID:
24403285
30.

Mood and coping in clinically isolated syndrome and multiple sclerosis.

Bianchi V, De Giglio L, Prosperini L, Mancinelli C, De Angelis F, Barletta V, Pozzilli C.

Acta Neurol Scand. 2014 Jun;129(6):374-81. doi: 10.1111/ane.12194. Epub 2013 Oct 30.

PMID:
24172013
31.

Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis.

Prosperini L, Mancinelli CR, De Giglio L, De Angelis F, Barletta V, Pozzilli C.

Mult Scler. 2014 Apr;20(5):566-76. doi: 10.1177/1352458513502399. Epub 2013 Sep 2.

PMID:
23999607
32.

Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.

Pastò L, Portaccio E, Ghezzi A, Hakiki B, Giannini M, Razzolini L, Piscolla E, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, La Mantia L, Mancardi GL, Solaro C, Totaro R, Tola MR, Di Tommaso V, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

BMC Neurol. 2012 Dec 31;12:165. doi: 10.1186/1471-2377-12-165.

33.

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.

Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Piscolla E, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, La Mantia L, Mancardi G, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP.

BMC Neurol. 2012 Oct 22;12:124. doi: 10.1186/1471-2377-12-124.

34.

Determinants of the severity of comorbid migraine in multiple sclerosis.

Villani V, De Giglio L, Sette G, Pozzilli C, Salvetti M, Prosperini L.

Neurol Sci. 2012 Dec;33(6):1345-53. doi: 10.1007/s10072-012-1119-5. Epub 2012 May 27.

PMID:
22644131
35.

The impact of interferon beta and natalizumab on comorbid migraine in multiple sclerosis.

Villani V, Prosperini L, De Giglio L, Pozzilli C, Salvetti M, Sette G.

Headache. 2012 Jul-Aug;52(7):1130-5. doi: 10.1111/j.1526-4610.2012.02146.x. Epub 2012 Apr 5.

PMID:
22486199
36.

Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis.

Prosperini L, Giannì C, Leonardi L, De Giglio L, Borriello G, Galgani S, Pozzilli C, Gasperini C.

Mult Scler. 2012 Jan;18(1):64-71. doi: 10.1177/1352458511417481. Epub 2011 Aug 9.

PMID:
21828195
37.

Breastfeeding is not related to postpartum relapses in multiple sclerosis.

Portaccio E, Ghezzi A, Hakiki B, Martinelli V, Moiola L, Patti F, La Mantia L, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, De Luca G, Paolicelli D, Marrosu MG, Comi G, Trojano M, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2011 Jul 12;77(2):145-50. doi: 10.1212/WNL.0b013e318224afc9. Epub 2011 Jul 6.

PMID:
21734184
38.

Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?

Prosperini L, Borriello G, De Giglio L, Leonardi L, Barletta V, Pozzilli C.

BMC Neurol. 2011 Feb 25;11:26. doi: 10.1186/1471-2377-11-26.

39.

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis.

Amato MP, Portaccio E, Ghezzi A, Hakiki B, Zipoli V, Martinelli V, Moiola L, Patti F, La Mantia L, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, Di Tommaso V, Paolicelli D, Marrosu MG, Comi G, Pellegrini F, Trojano M; MS Study Group of the Italian Neurological Society.

Neurology. 2010 Nov 16;75(20):1794-802. doi: 10.1212/WNL.0b013e3181fd62bb.

PMID:
21079181
40.

Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.

Tomassini V, De Giglio L, Reindl M, Russo P, Pestalozza I, Pantano P, Berger T, Pozzilli C.

Mult Scler. 2007 Nov;13(9):1086-94. Epub 2007 Apr 27.

PMID:
17468447
41.

Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience.

Pozzilli C, Prosperini L, Sbardella E, De Giglio L, Onesti E, Tomassini V.

Neurol Sci. 2005 Dec;26 Suppl 4:S174-8.

PMID:
16388353

Supplemental Content

Loading ...
Support Center